Chinese firms still want Nvidia chips despite Beijing pressure not to buy, sources say


Alibaba Group Holding, ByteDance and other Chinese tech firms remained keen on Nvidia’s artificial intelligence chips despite regulators in Beijing strongly discouraging them from such purchases, four people with knowledge of procurement discussions said.
They wanted reassurance that their orders of Nvidia’s H20 model, which the US firm in July regained permission to sell in China, were being processed, and were closely monitoring Nvidia’s plans for a more powerful chip, tentatively named the B30A and which is based on its Blackwell architecture, two of the people said.

The B30A – if approved for sale by Washington – was likely to cost about double the H20, which currently sells for between US$10,000 and US$12,000, those two people said.

Chinese tech firms perceived the potential B30A pricing as a good deal, they added. One said the B30A promised to be up to six times more powerful than the H20.

Both chips are downgraded versions of models sold outside China, developed specifically to comply with US export restrictions.

An Nvidia chip is displayed during the China International Supply Chain Expo in Beijing in July. Photo: AFP
An Nvidia chip is displayed during the China International Supply Chain Expo in Beijing in July. Photo: AFP

All sources for this article were not authorised to speak to the media and declined to be identified.

  • Related Posts

    Siam Piwat redefines global retail with NEXTOPIA, a future prototype where sustainability is a transformative force for business, people, and the planet

    [The content of this article has been produced by our advertising partner.] In a bold bid to reshape the future of retail, Siam Piwat Group has unveiled NEXTOPIA at its…

    Continue reading
    Leaders Shape the Future of Healthcare at ASGH 2026- Asia’s Premier Health Event

      [The content of this article has been produced by our advertising partner.] In an era defined by scientific acceleration, geopolitical complexity and rising expectations for healthcare delivery, one truth…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *